"An additional strength is that this [study] isn't trying to tease out only those admitted with RSV pneumonia," he added. "We've known for a while that some heart attacks are triggered by the ...
Quentin University, INSERM U1173, Paris, France. The study included 695 infants with RSV infection, of whom 349 had received nirsevimab prophylaxis. RSV-A was predominant this season, found in 86. ...
infections across six RSV seasons, roughly one in 20 were hospitalized within 28 days, according to a large cohort study that used data from three health record databases. In the cohort of over ...
in New York City, and colleagues examined the absolute risk for 28-day all-cause hospitalization following outpatient MA-RSV infection in adults in a cohort study using data from three databases ...
Two studies published today show more promising evidence that the respiratory syncytial virus (RSV) antibody, nirsevimab, is an effective way to protect infants from illness. Protection against ...
Respiratory syncytial virus (RSV) causes cold-like symptoms in most people but can cause more serious problems in some, especially babies and older adults. Almost all children get RSV at least once by ...
and by the low RSV incidence during the study period, Scobie noted. Other limitations included a lack of data on nirsevimab dosage and potential lack of generalizability of the data to other ...
Do you not know? Have you not heard? The LORD is the everlasting God, the Creator of the ends of the earth. He will not grow tired or weary, and his understanding no one can fathom. Have you never ...
16 1 To humans belong the plans of the heart, but from the Lord comes the proper answer of the tongue. 2 All a person's ways seem pure to them, but motives are weighed by the Lord. 3 Commit to the ...